For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

An update on the execution of the two Phase 3 DIAMOND trials of OCS-01 eye drops in diabetic macular edema (DME), with enrollment for both studies completed (>800 patients) and topline data ...

Adam Bešić’s life journey began in a small old town by the Una River, in Bosanska Otoka, and today it leads him through ...

Recent research indicates that semaglutide, a medication often prescribed for diabetes management, may be associated with an elevated risk of developing nonarteritic anterior ischemic optic neuropathy ...

Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...

TUESDAY, April 8, 2025 (HealthDay News) — For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a ...

WATERTOWN — The city’s Public Works Commission opted against giving a favorable letter to Bug Tussel Wireless for city-wide fiber optic internet installation during Tuesday evening’s meeting.